Physician

John A Watson, MD

According to 2025 Medicare claims, John Watson, MD (NPI: 1962662312) practices urology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 08690-3403. Watson is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Watson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 680 traditional Medicare patients, billed 19,198 HCPCS/CPT codes, and received $423,686 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,817 prescription claims across 784 beneficiaries totaling $1,933,544 in drug costs, led by Xtandi (Enzalutamide). 2021 DME data shows 23 claims. Open Payments data shows 3 records totaling $49. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $425,641 and ending at $423,686. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $730,420 to $1,933,544. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	768	5,857	$425,641
2016	846	8,873	$550,940
2017	718	6,269	$248,984
2018	911	12,312	$425,497
2019	851	9,512	$304,676
2020	668	13,246	$290,823
2021	674	16,179	$470,595
2022	770	14,474	$393,376
2023	699	20,843	$423,585
2024	680	19,198	$423,686

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	401	1,720	$730,420
2016	458	2,116	$618,118
2017	524	2,433	$795,952
2018	587	2,974	$1,436,928
2019	608	3,161	$1,346,545
2020	587	2,859	$974,592
2021	544	2,524	$919,187
2022	743	3,202	$1,496,207
2023	769	3,676	$2,102,066
2024	784	3,817	$1,933,544

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	16	$256
2016	N/R	30	$526
2017	N/R	29	$3,655
2018	N/R	11	$203
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	23	$82
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	461	926	$96
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	262	395	$63
76857	Limited ultrasound scan of pelvis	103	120	$35
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	175	227	$13
51741	Electronic assessment of bladder emptying	223	267	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	77	2,310	$1,080,363
Myrbetriq	Mirabegron	605	28,411	$417,701
Erleada	Apalutamide	12	360	$179,239
Gemtesa	Vibegron	125	6,650	$102,330
Abiraterone Acetate	Abiraterone Acetate	33	894	$22,423

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$49	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John A. Watson, MD?

Tedicare shows public-source Medicare data for John A. Watson, MD (NPI 1962662312), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John A. Watson, MD have ACO affiliation data?

John A. Watson, MD is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to John A. Watson, MD?

John A. Watson, MD is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does John A. Watson, MD have Open Payments data?

John A. Watson, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.